|
|
|
Insider
Information: |
Sherman Matthew L |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
197,506 |
|
Indirect Shares
|
8,500 |
|
|
Direct
Value |
$15,060,596 |
|
|
Indirect Value
|
$1,519,375 |
|
|
Total
Shares |
206,006 |
|
|
Total
Value |
$16,579,971 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
8
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.6
|
Percentage
Gain/Loss : |
0.0%
|
374.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acceleron Pharma Inc |
XLRN |
EVP & Chief Medical Of... |
2018-04-03 |
68,767 |
2018-04-03 |
8,500 |
Premium* |
|
Pulmatrix Inc |
PULM |
Director |
2018-04-03 |
20,000 |
2018-04-03 |
0 |
Premium* |
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2024-02-16 |
108,739 |
2019-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical OfficerOff |
|
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,922 |
|
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical OfficerOff |
|
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
37,500 |
|
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-04-22 |
4 |
AS |
$35.64 |
$143,412 |
D/D |
(4,000) |
15,922 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-04-22 |
4 |
AS |
$35.75 |
$35,750 |
I/I |
(1,000) |
36,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-05-19 |
4 |
AS |
$31.47 |
$63,016 |
D/D |
(2,000) |
15,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-05-19 |
4 |
AS |
$31.68 |
$15,840 |
I/I |
(500) |
36,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-05-28 |
4 |
AS |
$30.97 |
$185,820 |
D/D |
(6,000) |
15,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-05-28 |
4 |
OE |
$0.48 |
$2,880 |
D/D |
6,000 |
21,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-05-28 |
4 |
AS |
$30.99 |
$46,485 |
I/I |
(1,500) |
34,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-06-11 |
4 |
OE |
$0.48 |
$2,880 |
D/D |
6,000 |
21,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-06-11 |
4 |
AS |
$33.23 |
$199,380 |
D/D |
(6,000) |
15,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-06-11 |
4 |
AS |
$33.25 |
$49,875 |
I/I |
(1,500) |
33,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-06-18 |
4 |
AS |
$34.49 |
$68,980 |
D/D |
(2,000) |
13,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-06-18 |
4 |
AS |
$34.13 |
$17,065 |
I/I |
(500) |
32,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-09 |
4 |
AS |
$28.77 |
$43,499 |
I/I |
(1,500) |
31,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-09 |
4 |
AS |
$28.55 |
$173,899 |
D/D |
(6,000) |
13,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-09 |
4 |
OE |
$0.48 |
$2,880 |
D/D |
6,000 |
19,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-18 |
4 |
AS |
$26.39 |
$52,793 |
D/D |
(2,000) |
11,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-18 |
4 |
AS |
$25.50 |
$12,750 |
I/I |
(500) |
30,500 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-07-23 |
4 |
OE |
$1.80 |
$18,000 |
D/D |
10,000 |
21,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-08-12 |
4 |
OE |
$1.80 |
$14,400 |
D/D |
8,000 |
29,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-08-14 |
4 |
AS |
$29.82 |
$44,730 |
I/I |
(1,500) |
29,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-08-14 |
4 |
AS |
$29.77 |
$178,668 |
D/D |
(6,000) |
29,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-08-14 |
4 |
OE |
$0.48 |
$8,577 |
D/D |
6,000 |
35,858 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP & Chief Medical Officer |
|
2014-08-18 |
4 |
AS |
$29.53 |
$59,060 |
D/D |
(2,000) |
27,858 |
0 |
- |
|
122 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|